82 results found

On 3 September 2025, the Federal Council published the dispatch regarding the partial revision of the Therapeutic Products Act (TPA) to be submitted to Parliament.

With our unique focus on the Life Sciences and Healthcare sectors, we've stayed at the forefront of current trends and developments in these industries.

Seit dem 1. Juli 2021 gelten neue Zulassungsbeschränkungen für angestellte Ärztinnen und Ärzte. Die Kantone haben bis 2023 Zeit für die Umsetzung.

In den letzten zwei Jahrzehnten hat der Gesundheits- sektor bedeutsame technologische Entwicklungen durchlaufen.

It was almost 25 years ago, during the NBA season 1991/1992, that the great US basketball player Earvin 'Magic' Johnson Jr. was tested positive for HIV during a standard medical check.

The Australian Government is not accepting new applications for the "Business Innovation and Investment Program", also known as the "Golden Visa" program.

Since 2001, Switzerland has regulated medical devices in the same way as the EU. The former EU Directives on classical medical devices (93/42/EEC), ...

Switzerland has had to constantly adapt its legislation in this area to align with the heightened standards imposed by the EU.

L’arrêt rendu le 29 avril 2026 par le Tribunal administratif fédéral suisse (TAF) dans l'affaire B-6574/2025 (CF & C Finance Suisse SA et Swiss DermaCosmetics SA contre Mossad Abounahi...

On this episode of Women @ RopesTalk hosted by health care and data partner Christine Moundas, IP transactions and licensing partner Megan Baca engages in a fascinating conversation with Laura Berner...

Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.

According to Swiss nomenclature, the term therapeutic products covers medicinal products as well as medical devices.

Clinical data may originate from multiple countries, arrive in different languages, and exist across hundreds of documents and file formats. Scanned PDFs, handwritten annotations, redactions, missing source files, and unexpected language requirements can add significant complexity to an already compressed regulatory timeline.

Switzerland's medical device regulatory framework in 2026 presents a complex landscape shaped by alignment with EU standards, post-Brexit market access challenges, and evolving requirements for product registration and transparency. How do manufacturers navigate classification systems, conformity assessments, and post-market surveillance obligations while managing the implications of Switzerland's third-country status for medical devices in the European Union?

Medicinal products are products of chemical or biological origin which are intended or claimed to have a medicinal effect on the human organism, in particular in the diagnosis, prevention or treatment of diseases...

Swiss healthcare regulation is spread over various statutes, ordinances and guidelines, including self-regulatory instruments such as best practice codes and references to international provisions.

In Switzerland, the product safety regulation of therapeutic products (medicinal products and medical devices), consumer healthcare products and new products/technologies...

In Switzerland, the regulation pertaining to the advertisement and promotion of medicines is spread over various statutes, ordinances and guidelines, and also includes self-regulatory codes.